Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Iris Kramer(The Netherlands Cancer Institute), Margit Riis(Gentofte Hospital), Olav Engebråten(University of Oslo), Marina Bermisheva(Russian Academy of Sciences), Hiltrud Brauch(German Cancer Research Center), Sander Canisius(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Jose E. Castelao(Servicio Gallego de Salud), Jenny Chang‐Claude(Universität Hamburg), Kristin V. Reinertsen(Oslo University Hospital), Sara Y. Brucker(University Children's Hospital Tübingen), Cecile E. Kiserud(University of Southampton), Heiko Becher(Universität Hamburg), Kristine Kleivi Sahlberg(University of Oslo), Antonis C. Antoniou(Weatherford College), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Michael Hauptmann(Medizinische Hochschule Brandenburg Theodor Fontane), Nasim Mavaddat(MRC Epidemiology Unit), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Christine L. Clarke(Memorial University of Newfoundland), Åslaug Helland(Oslo University Hospital), Alexander Fosså(Oslo University Hospital), Michael Bremer(Medizinische Hochschule Hannover), Marit Muri Holmen(Unknown), Vilde Drageset Haakensen(University of Oslo), Toril Sauer(Leiden University Medical Center), Zumuruda Abu-Ful(Carmel Medical Center), Maartje J. Hooning(Erasmus MC Cancer Institute), Ji‐Yeob Choi(Seoul National University), Daniele Giardiello(University of Milano-Bicocca), Stig E. Bojesen(University of Copenhagen), Renske Keeman(The Netherlands Cancer Institute), Hoda Anton‐Culver(University of California, Irvine), Lars Ottestad(Norwegian Cancer Society), Bernardo Bonanni(European Institute of Oncology), Rolf Kåresen(Oslo University Hospital), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Kristan J. Aronson(Queen's University), Ewout W. Steyerberg(Erasmus MC), Stephen J. Chanock(National Cancer Institute), Tsun Leung Chan(University of Hong Kong), Ellen Schlichting(Oslo University Hospital), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Anne‐Lise Børresen‐Dale(Oslo University Hospital), Bjørn Naume(Norwegian Cancer Society), Manjeet K. Bolla(University of Cambridge), Annelie Augustinsson(Lund University)
Cited by 72
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k